Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1985;13(5):209-12.
doi: 10.1007/BF00261577.

Comparison between continuous and intermittent administration of Estracyt in the treatment of carcinoma of the prostate

Clinical Trial

Comparison between continuous and intermittent administration of Estracyt in the treatment of carcinoma of the prostate

W Vahlensieck et al. Urol Res. 1985.

Abstract

Ninety-five patients with prostatic carcinoma, stages A-D and of all histological grades were randomized between a continuous and an intermittent treatment regimen of Estracyt (estramustine phosphate). 77 patients were evaluated (46 with continuous and 31 with intermittent therapy). Remissions were seen in 13 (28%) and (13%), respectively. Stable disease was recorded in 30 (65%) and 24 (77%), respectively. Progression experienced 3 (6%) and 3 (10%) respectively. 19% were unable to continue therapy due to intolerable gastrointestinal side effects (7 patients receiving continuous and 8 patients receiving intermittent therapy).

PubMed Disclaimer

References

    1. Am J Nurs. 1982 May;82(5):829-30 - PubMed
    1. Scand J Urol Nephrol. 1977;11(3):231-8 - PubMed
    1. Biometrika. 1965 Jun;52:203-23 - PubMed
    1. Scand J Urol Nephrol. 1981;15(1):37-44 - PubMed
    1. J Urol. 1977 Dec;118(6):1013-8 - PubMed

LinkOut - more resources